Effect of the polymorphism of the angiotensin-converting enzyme gene on the plasma angiotensin II levels and the risk of chronic heart failure

Journal of Central South University (Medical Sciences)

Volumn 29, Issue 2, 2004, Pages 198-200

  Huan, Wen Yan ^a   Sun, Ming ^a   Zhou, Hong Yan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Chronic; Gene; Heart failure; Peptidyl dipeptidase A; Polymorphism

Indexed keywords

ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BLOOD; CONGESTIVE HEART FAILURE; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ALLELES; ANGIOTENSIN II; FEMALE; GENOTYPE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 39049194135     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels [J]. J Clin Invest, 1990, 86(4):1343-1346. (Pubitemid 20370444)
2. Costerousse O, Allegrini J, Lopez M, et al. Angiotensin converting enzyme in human circulatory mononuclear cells: genetic polymorphism of expression in T-lymphocytes [J]. Biochem J, 1993, 290(pt 1):33-40. (Pubitemid 23081197)
3. Danser AHJ, Schalekamp MADH, Box WA, et al. Angiotensinconverrting enzyme in the human heart: effect of the deletion/insertion polymorphism [J]. Circulation, 1995, 92(6):1387-1388
4. Tiret L, Mallet C, Poirer O, et al. Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the cardigene study [J]. J Am Coll Cardiol, 2000, 35(1):29-35. (Pubitemid 30061255)
5. McNamara DM, Holubkov R, Janosko K, et al. Pharmacogenetic interactions between β-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failure [J]. Circulation, 2001, 103(12):1644-1648. (Pubitemid 32246611)
6. Rigat B, Hubert C, Corvol P, et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1) [J]. Nucleic Acids Res, 1992, 20(6):1433.
7. Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischaemic heart disease [J]. N Engl J Med, 1995, 332(11):706-711.
8. Candy GP, Skudicky D, Mueller U, et al. Association of left ventricular systolic performance and cavity size with angiotensin 2con2 verting enzyme genotype in idiopathic dilated cardiomyopathy [J]. Am J Cardiol, 1999, 83(5):740-744. (Pubitemid 29115447)
9. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction [J]. Nature, 1992, 359(6396):641-644.
10. Shunckert H, Hense HW, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin converting enzyme gene and left ventricular hypertrophy [J]. N Engl J Med, 1994, 330(23):1634-1638.
11. Ueda S, Elliot HL, Morton JJ, et al. Enhanced pressor response to angiotensin in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme [J]. Hypertension, 1995, 25(6):1266-1264.
12. McNamara DM, Holubkov R, Janosko K, et al. Pharmaco genetic interactions between-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failure [J]. Circulation, 2001, 103(12):1644-1648. (Pubitemid 32246611)